Stay updated on Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Updated the page versioning: added revision v3.5.0 and removed revision v3.4.3. This updates metadata rather than core study content.
    Difference
    0.1%
    Check dated 2026-03-18T17:44:41.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:27:14.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 and the older funding-status notice (v3.4.1) was removed. No changes to study details, eligibility criteria, or navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:27:43.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    - Added a site-wide notice about a lapse in government funding and NIH Clinical Center status with references to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-03T23:44:05.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Footer and header metadata were updated to include new labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', the glossary toggle option, and a revision note 'Revision: v3.4.0'. No changes were made to the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-27T21:14:56.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    A unified Locations section appears with Illinois and Massachusetts, replacing prior separate location headings. The revision is updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T09:10:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.